Steroid hormone receptors induce genes by virtue of their interaction with DNA regulatory sequences. The hormonal response of a particular gene in vivo correlates with binding of the hormone to the receptor and supposedly reflects the degree of occupancy of the corresponding DNA regulatory sequences. However, in vitro the steroid-free glucocorticoid and progesterone receptors bind specifically to the regulatory sequences of mouse mammary tumor virus, thus raising questions on the role of the hormone in DNA binding in vivo. By using monoclonal antibodies, gel retardation assays, and filter binding techniques we show here that binding of a functional steroid to either the glucocorticoid or the progesterone receptors influences the kinetics of the protein-DNA interaction in vitro. In the presence of hormone the on rate of receptor binding to DNA fragments with or without regulatory sequences is accelerated 2-to 5-fold, and the off rate is accelerated 10-to 20-fold. The receptors complexed to an antihormone bind to DNA with kinetics intermediate between those of the steroid-free and the hormone-bound protein. Thus, ligand binding accelerates the kinetics of receptor binding to DNA and this could partly account for the behavior of the hormone receptor observed in vivo.The cis elements that mediate gene induction by steroid hormones are hormone-dependent enhancers (1) and have been designated hormone-responsive or -regulatory elements (HREs). The trans-acting factors that interact with the HREs are the steroid hormone receptors, a family of proteins that has been widely studied due to their ability to specifically bind the corresponding hormone. The domain of the receptor that binds the steroid hormone is located in a large region of the C-terminal half of the protein and is separated from the DNA-binding domain by a hinge region (2). Exactly how the DNA-binding domain and the steroid-binding domain of the receptor interact is not known.The magnitude of the hormone response observed in vivo correlates with the degree of saturation of the corresponding receptor (see, for instance, ref.3). According to the prevailing view, binding of the hormone to the receptor is followed by a conformational change of the protein leading to the exposition of the preformed DNA-binding domain that is masked in the hormone-free receptor (1). Whether this masking is accomplished intramolecularly by the steroidbinding domain or intermolecularly by interaction with other factors, such as the 90-kDa heat shock protein, is a matter of debate (4). In cell fractionation studies one consequence of hormone administration is the association of the otherwise cytosolic receptor with the nuclear fraction, suggesting a tighter interaction with DNA in chromatin. In agreement with this model, the HRE of the tyrosine amino transferase gene in rat liver has been shown to be protected against methylation by dimethyl sulfate in vivo only after hormone administration, whereas no protection is detected prior to hormone treatment (5).To understand the p...